JPRN-jRCT2080221543未知3 期
A randomized, double-blind, double-dummy, parallel group, active controlled multi-center clinical trial to evaluate the additional efficacy and safety of Olmesartan Medoxomil/Amlodipine 20/5 mg in Chinese patients with mild or moderate essential hypertension who failed to achieve their goal with Olmesartan Medoxomil 20mg monotherapy
适应症
试验速览
- 阶段
- 3 期
- 入组人数
- 252
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 18age old 至 <= 75age old（—）
- 性别
- All
入选标准
- •Outpatients with mild or moderate essential hypertension if they satisfy the following main inclusion criteria:
- •-Male or female, age of 18-75 years (inclusive);
- •-At visit 3, Mean SeDBP >= 95 mmHg and <110 mmHg;
- •-At visit 4, Mean SeDBP >= 90 mmHg;
- •-No significant abnormality in hematology, kidney, liver, cardiovascular or endocrinology system;
- •-Subject was willing and able to take study medications as prescribed and complied with other study requirements;
- •-Subject was able to give his/her written informed consent to participate in this study.
- •During the whole study, the subject will be removed from the study immediately and given appropriate treatment if his/her mean SeDBP>=110 mmHg and/or mean SeSBP>=180 mmHg.
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
1 期
Study of efficacy and safety of ofatumumab compared to teriflunomide in patients with relapsing forms of multiple sclerosisMedDRA version: 20.0Level: PTClassification code 10048393Term: Multiple sclerosis relapseSystem Organ Class: 10029205 - Nervous system disordersmultiple sclerosisEUCTR2015-005418-31-EEovartis Pharma Services AG900
进行中（未招募）
1 期
Efficacy and safety of remibrutinib compared to teriflunomide in participants with relapsing multiple sclerosis, followed by long term treatment with remibrutinibMedDRA version: 27.0Level: PTClassification code 10080700Term: Relapsing multiple sclerosisSystem Organ Class: 10029205 - Nervous system disordersMultiple SclerosisEUCTR2020-005929-89-PLovartis Pharma AG800
进行中（未招募）
1 期
Study of efficacy and safety of ofatumumab compared to teriflunomide in patients with relapsing forms of multiple sclerosisMedDRA version: 20.0Level: PTClassification code 10048393Term: Multiple sclerosis relapseSystem Organ Class: 10029205 - Nervous system disordersmultiple sclerosisEUCTR2015-005419-33-HUovartis Pharma Services AG1,313
进行中（未招募）
1 期
Study of efficacy and safety of ofatumumab compared to teriflunomide in patients with relapsing forms of multiple sclerosismultiple sclerosisMedDRA version: 20.0Level: PTClassification code 10048393Term: Multiple sclerosis relapseSystem Organ Class: 10029205 - Nervous system disordersEUCTR2015-005419-33-DEovartis Pharma Services AG1,313
进行中（未招募）
1 期
Efficacy and safety of a progestin and an aromatase inhibitor combined in a intravaginal ring in symptomatic endometriosis.MedDRA version: 19.0Level: LLTClassification code 10014788Term: Endometriosis related painSystem Organ Class: 10038604 - Reproductive system and breast disordersMedDRA version: 19.0Level: PTClassification code 10014778Term: EndometriosisSystem Organ Class: 10038604 - Reproductive system and breast disordersEndometriosisEUCTR2013-005090-53-ATBayer AG318